News

• Jeffrey Popma, MD, Joins CRF as Chief Scientific and Strategic Officer
• Symbiosis Wins TCT 2024 Shark Tank Innovation Competition
• First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of Peripheral Artery Disease: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
• Randomized Trial Demonstrates Benefits of Large-bore Mechanical Thrombectomy Over Catheter-directed Thrombolysis for Treatment of Intermediate-risk Pulmonary Embolism
• Routine Colchicine Administration After Acute Myocardial Infarction Does Not Improve Outcomes
• Orbital Atherectomy Prior to Coronary Stent Implantation Does Not Lead to Better Outcomes Compared to Conventional Balloon Angioplasty
• Transcatheter Aortic Valve Replacement in Patients with Systolic Heart Failure and Moderate Aortic Stenosis Shows Limited Benefits
• Early Intervention in Patients with Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis Falls Short of Expected Benefits
• Study Finds Early TAVR Can Be Beneficial for Patients with Asymptomatic Severe Aortic Stenosis
• CRF Announces 2024 SET-10 Rankings
• MedTech Innovation Takes Center Stage at TCT 2024
• CRF Announces TCT 2024 Late-Breaking Clinical Trials and Science
• New York Valves 2024 Late-Breaking Clinical Trials and Science Announced
• TCT 2024 Master Operator Award to Be Presented to Jeffrey W. Moses, MD
• TCT 2024 Career Achievement Award to be Presented to Robert A. Harrington, MD
• AATS and CRF Partner on New York Valves: The Structural Heart Summit
• Introducing New York Valves: The Structural Heart Summit
• Media Registration for TCT 2024 Now Open
• THT 2024 Late-Breaking Clinical Science Announced